HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutsuo Yamaya Selected Research

Carboxyhemoglobin

4/2006Arterial carboxyhemoglobin concentrations as a prognostic predictor in elderly patients with advanced non-small-cell lung cancer.
2/2006Arterial carboxyhemoglobin concentrations as a predictor of chemosensitivity in elderly patients with advanced lung cancer.
6/2005Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease.
9/2004Arterial carboxyhemoglobin concentrations in elderly patients with operable non-small cell lung cancer.
8/2004Increased arterial carboxyhemoglobin concentrations in elderly patients with silicosis.
6/2004Increased arteriovenous carboxyhemoglobin differences in patients with inflammatory pulmonary diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mutsuo Yamaya Research Topics

Disease

38Infections
10/2021 - 01/2002
25Chronic Obstructive Pulmonary Disease (COPD)
05/2020 - 06/2005
24Inflammation (Inflammations)
01/2021 - 01/2002
13Asthma (Bronchial Asthma)
05/2020 - 01/2002
10Virus Diseases (Viral Diseases)
01/2018 - 08/2002
8Pneumonia (Pneumonitis)
01/2020 - 02/2002
7Human Influenza (Influenza)
10/2021 - 03/2009
7Common Cold
01/2021 - 01/2003
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2012 - 09/2004
5Neoplasms (Cancer)
07/2012 - 10/2005
4Aspiration Pneumonia
03/2015 - 01/2002
4Adenocarcinoma of Lung
07/2012 - 04/2005
3Emphysema
01/2020 - 01/2002
3Disseminated Intravascular Coagulation
01/2020 - 10/2005
3Lung Injury
03/2016 - 03/2003
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2015 - 02/2002
3Bacterial Infections (Bacterial Infection)
08/2012 - 01/2002
3Lewis Lung Carcinoma
07/2012 - 10/2005
3Lung Neoplasms (Lung Cancer)
05/2011 - 02/2006
3Lung Diseases (Lung Disease)
06/2005 - 01/2002
2Respiratory Sounds (Crackle)
05/2020 - 04/2012
2Leukocytosis (Pleocytosis)
01/2020 - 05/2018
2Hyperplasia
05/2016 - 01/2006
2Fever (Fevers)
01/2015 - 09/2014
2Acute Lung Injury
02/2012 - 09/2005
2Fibrosis (Cirrhosis)
02/2012 - 12/2007
2Pulmonary Emphysema
03/2003 - 01/2002
1COVID-19
01/2020
1Lymphopenia (Lymphocytopenia)
01/2020
1Hypoalbuminemia
01/2020
1Hypoproteinemia
01/2020

Drug/Important Bio-Agent (IBA)

25CytokinesIBA
01/2021 - 04/2002
17Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2020 - 01/2002
15RNA (Ribonucleic Acid)IBA
05/2020 - 01/2002
13Interleukin-6 (Interleukin 6)IBA
05/2020 - 10/2005
11MacrolidesIBA
05/2020 - 10/2005
9InterleukinsIBA
01/2016 - 04/2010
9Anti-Bacterial Agents (Antibiotics)IBA
10/2015 - 10/2005
8Proteins (Proteins, Gene)FDA Link
05/2020 - 11/2006
7NF-kappa B (NF-kB)IBA
05/2020 - 08/2002
7Interleukin-8 (Interleukin 8)IBA
05/2020 - 01/2012
6Viral RNAIBA
05/2020 - 04/2002
6CarboxyhemoglobinIBA
04/2006 - 06/2004
4nafamostatIBA
10/2021 - 01/2015
4Clarithromycin (Biaxin)FDA LinkGeneric
05/2020 - 08/2009
4Adrenal Cortex Hormones (Corticosteroids)IBA
05/2020 - 10/2011
4MucinsIBA
09/2016 - 12/2006
4Expectorants (Mucolytics)IBA
05/2016 - 09/2009
4Messenger RNA (mRNA)IBA
10/2015 - 02/2005
4Cholinergic Antagonists (Anticholinergics)IBA
08/2012 - 04/2007
4Histamine (Histamine Dihydrochloride)FDA Link
01/2012 - 08/2002
4Erythromycin (Erycette)FDA LinkGeneric
04/2007 - 04/2002
4Carbon MonoxideIBA
05/2006 - 01/2002
3Hemagglutinins (Hemagglutinin)IBA
10/2021 - 08/2015
3Neuraminidase (Sialidase)IBA
10/2021 - 09/2014
3InterferonsIBA
01/2020 - 01/2012
3AlbuminsIBA
01/2020 - 05/2018
3Peptide Hydrolases (Proteases)FDA Link
01/2020 - 08/2015
3AntioxidantsIBA
01/2018 - 02/2002
3Pharmaceutical PreparationsIBA
10/2015 - 04/2014
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2015 - 02/2002
3ICI 118551IBA
07/2014 - 01/2011
3Nitroglycerin (Dynamite)FDA LinkGeneric
07/2012 - 02/2006
3Proton Pump InhibitorsIBA
04/2011 - 02/2005
3Interleukin-1beta (Interleukin 1 beta)IBA
11/2006 - 02/2005
2Formoterol Fumarate (Oxis)FDA Link
05/2020 - 07/2014
2Interleukin-33IBA
05/2020 - 01/2018
2Budesonide (Pulmicort)FDA LinkGeneric
05/2020 - 07/2014
2Oxygen (Dioxygen)IBA
01/2020 - 04/2007
2camostatIBA
01/2020 - 08/2015
2Interleukin-1 (Interleukin 1)IBA
01/2018 - 01/2012
2Poly I-CIBA
01/2018 - 09/2016
2Biological ProductsIBA
05/2016 - 04/2007
2Receptor for Advanced Glycation End ProductsIBA
03/2016 - 12/2007
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
08/2015 - 01/2015
2Dacarbazine (DIC)FDA LinkGeneric
01/2015 - 10/2005
2E-SelectinIBA
03/2014 - 12/2012
2Leukocyte Elastase (Neutrophil Elastase)IBA
02/2012 - 06/2009
2Bronchodilator Agents (Bronchodilators)IBA
10/2011 - 08/2009
2N-Acetylneuraminic Acid (Sialic Acid)IBA
08/2010 - 04/2010
2bafilomycin AIBA
04/2010 - 08/2009
2Lansoprazole (Prevacid)FDA LinkGeneric
08/2009 - 02/2005
2Pancreatic Elastase (Elastase)IBA
08/2008 - 03/2003
2Interleukin-13IBA
05/2008 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2006 - 10/2005
2Carboplatin (JM8)FDA LinkGeneric
11/2006 - 04/2006
2Heme Oxygenase-1IBA
04/2005 - 01/2002
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2004 - 01/2002
2Amantadine (Aman)FDA LinkGeneric
07/2003 - 01/2002
2Substance PIBA
07/2003 - 01/2002
2BilirubinIBA
03/2003 - 02/2002
1EnzymesIBA
10/2021
1kakkon-toIBA
01/2021
1Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
05/2020
1Muscarinic AntagonistsIBA
05/2020
1Ritonavir (Norvir)FDA Link
01/2020

Therapy/Procedure

7Therapeutics
01/2021 - 01/2002
3Aftercare (After-Treatment)
11/2006 - 01/2003
2Drug Therapy (Chemotherapy)
11/2006 - 01/2006
1Kampo Medicine (Kampo)
01/2021